At the end of the article we notice the name of MEDTRONIC. Add 2 + 2 and you get MEDTRONIC buyout of ETRM. It is so obvious, here is the rest:
This project was supported by the International Neuromodulation Society, and was partially funded by a series of unrestricted educational grants from Medtronic Inc., St. Jude Medical Inc., Boston Scientific Corp., Nevro Corp., and Spinal Modulation Inc. No corporate entities had any direct input into the contents of this manuscript, or the conclusions of the collaborators.
Wow, 70 to 80% margins, that is awesome.
So $ 100 million in sales is $ 1 per share in earnings at 30x earnings, is a $ 30 stock.
A $ 100 million sales can easily be hit; talk about deal of a lifetime.
For September options for 10,900 shares bought at the ask price. There were no bidding price. Someone must know something. If it goes to $ 10 it is $ 80,000 return.
Could it be GSK buyout bid, someone in the know?
Kind of strange to cover the $ 5 and $ 7.50 calls which are so far away in terms of price versus 3 days of trading. Even the $ 2.50 doesn't make much sense.
If we see $ 9 buyout from GSK then we will know.
Mankind license deal only 7 weeks after FDA approval tells me ETRM will either be bought out or structure similar license deals.
Up we go....
Investors are going to roar back into biotech stocks, devices and pharma. What a jump in ICPT.
This rally that is just commencing in the biotech sector will light a FIRE.
We will bust through the 52 week high in no time at all. Watch as 7 million shorts scrabble to cover at the same time that investors flock into biotech stocks.
Can you say big $$$$$.
Others will follow. Didn't sell at all and not interested either as I see bidding war soon....
We are at a critical point where we will become industry leaders due to revolutionary technology which will begin to make pills obsolete. Big pharma must be concerned with this new technology which will take their bread and butter pills away. In the future VBLOC will be used to keep diebetic under control, then used to keep hypertension at normal levels and an unlimited host of other applications worth trillions of dollars.
We are the new iphone (body rewiring) which will put the rotary phone (pills) out of business.
HTLV-1 associated myelopathy
Hereditary Spastic Paraplegia
Heredopathia atactica polyneuritiformis
Herpes zoster oticus
Inclusion body myositis
Infantile Refsum disease
Klippel Feil syndrome
Lambert-Eaton myasthenic syndrome
Lateral medullary (Wallenberg) syndrome
Lewy body dementia
Lou Gehrig's disease (See amyotrophic lateral sclerosis)
Lumbar disc disease
Lumbar spinal stenosis
Lyme disease - Neurological Sequelae
Machado-Joseph disease (Spinocerebellar ataxia type 3)
Miller Fisher syndrome
Mini-stroke (transient ischemic attack)
Motor Neurone Disease - see amyotrophic lateral sclerosis
Motor skills disorder
Multifocal motor neuropathy
Multiple system atrophy
Myelinoclastic diffuse sclerosis
Myoclonic Encephalopathy of infants
Carpal tunnel syndrome
Central pain syndrome
Central pontine myelinolysis
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
Cervical spinal stenosis
Chronic fatigue syndrome
Chronic inflammatory demyelinating polyneuropathy (CIDP)
Complex regional pain syndrome
Congenital facial diplegia
Cumulative trauma disorders
Cytomegalic inclusion body disease (CIBD)
De Morsier's syndrome
Delayed sleep phase syndrome
Developmental coordination disorder
Duchenne muscular dystrophy
Empty sella syndrome
Exploding head syndrome
Familial spastic paralysis
Fetal alcohol syndrome
Fragile X syndrome
Fragile X-associated tremor/ataxia syndrome (FXTAS)
Giant cell arteritis
Giant cell inclusion disease
Globoid Cell Leukodystrophy
Gray matter heterotopia
I do believe that the list of diseases I put for VBLOC use is pretty complete. Any big pharma that does not see the writing on the wall with rewiring the body that will put their pills out of business, better get their heads checked.
The future is VBLOC and they are 12 years ahead of the competition and fully protected with patents on their technology.
As I said, I expect GSK to launch a hostile bid for ETRM which will be followed up with a friendlier one from Medtronic.
The applications for VBLOC are endless and we are speaking of trillions of dollars, not billions and not millions, trillions.
Better get in before it is too late and others jump in before you.
Finally the diseases with letters T, U, V, W, X and Y:
Tarsal tunnel syndrome
Tethered spinal cord syndrome
Thoracic outlet syndrome
Transient ischemic attack
Transmissible spongiform encephalopathies
Traumatic brain injury
Tropical spastic paraparesis
Von Hippel-Lindau disease (VHL)
Viliuisk Encephalomyelitis (VE)
Next the diseases with letter B:
Brachial plexus injury
VBLOC will re-wire the body and be used to cure the following other diseases, let's start with those of the letter A:
List of neurological conditions and disorders
Amyotrophic lateral sclerosis (ALS)
Attention deficit hyperactivity disorder
Auditory processing disorder
We know that ETRM has 13 Health Excellent services plus Mayo clinic which makes it 14 in total so far.
As the infrastructure is already in place and, there is a back log of patients per company awaiting device it means ETRM will come out running.
Lets play with some numbers:
If each center including May has about 700 patients waiting, which is not much per center, it means 10,000 patients to start with at $ 10,000 per device or $ 100 million in revenue.
Of course this is only the start, say there 100 salespeople bring in another 10,000 to 20,000 patients it means up to an additional $ 200 million in sales.
Now that we see some numbers and have idea of market, it won't be long before Wall Street takes notice.
I believe that GSK is preparing a bid for ETRM which will force Medtronic to bid on it too.
Thank-you. I am a type of individual whom will dig in for information just as I first did with my due diligence in ETRM. I have been saying for 1 year that ETRM is a gold mine in a new revolutionary device field and will become a leader. Their technology of rewiring the body to help cure some of the worst medical conditions where pills fail is the wave of the future. ETRM will first attack obesity, then next in line is people with diebetic, those with hypertension, then parkinson, multiple sclerosis, those with organ failures, etc....The applications are endless.
You said that MacDougall Investment has put out a MUST BUY on ETRM with an insane target price for their high worth individuals, estates and institutions they cater to?
Should be fun